Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicover ABLTS:0RPS +0.68%89 ROC (Joel Greenblatt) % is 16.86% as of Mar. 2026, which is 29% above its 10-year median of 13.02. GuruFocus rates LTS:0RPS with a GF Score™ of 89/100 and a GF Value™ of kr234.72 (Fairly Valued). The stock has 5 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Medicover AB ranks better than 56.2% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Medicover AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 16.86%.
The historical rank and industry rank for Medicover AB's ROC (Joel Greenblatt) % or its related term are showing as below:
LTS:0RPS'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 7.48 Med: 13.02 Max: 30.26
Current: 15.73
During the past 12 years, Medicover AB's highest ROC (Joel Greenblatt) % was 30.26%. The lowest was 7.48%. And the median was 13.02%.
LTS:0RPS's ROC (Joel Greenblatt) % is ranked better than 56.2% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 12.46
vs LTS:0RPS: 15.73
Medicover AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -6.80% per year.
Medicover AB (LTS:0RPS) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Medicover AB ROC (Joel Greenblatt) % Related Terms
Medicover AB ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Medicover AB's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0RPS vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Medicover AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicover AB ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Medicover AB's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 16.86% mean?
Medicover AB (LTS:0RPS) has a ROC (Joel Greenblatt) % of 16.86% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Medicover AB and its competitors. This is 29% above median its historical median of 13.02. Over the past decade, Medicover AB's ROC (Joel Greenblatt) % has ranged from 7.48 to 30.26. According to the industry distribution chart, Medicover AB ranks #293 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 43.8%.
Is Medicover AB's ROC (Joel Greenblatt) % too high?
Medicover AB's current ROC (Joel Greenblatt) % of 16.86% is 29% above median its 10-year median of 13.02. Over the past 10 years, this metric has ranged from a low of 7.48 to a high of 30.26. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.46. Medicover AB's value of 16.86% is 35.3% above this industry median. Based on the distribution chart, Medicover AB ranks #293 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medicover AB has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #293 out of 669 companies for ROC (Joel Greenblatt) %. This puts Medicover AB in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.46. Medicover AB's value of 16.86% is 35.3% above this benchmark. Historically, Medicover AB's own ROC (Joel Greenblatt) % has ranged from 7.48 to 30.26 over the past decade. While the company's 10-year median is 13.02 vs. the industry median of 12.46, Medicover AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.46, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicover AB's current ROC (Joel Greenblatt) % of 16.86% is 35.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Medicover AB and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicover AB's current ROC (Joel Greenblatt) % is 16.86%, which is 29% above median its own 10-year median of 13.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr234.72, compared to a current price of kr223.00 — trading 5% below its estimated fair value. The current ROC (Joel Greenblatt) % is 16.86%, which is 29% above median its 10-year median of 13.02 and 35.3% above the Healthcare Providers & Services industry median of 12.46. Medicover AB's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current ROC (Joel Greenblatt) % is 16.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicover AB (LTS:0RPS) Overvalued in 2026?
Based on GuruFocus' analysis, Medicover AB stock appears to be undervalued.
The current stock price of kr223.00 is trading 5% below its estimated GF Value™ of kr234.72.
GuruFocus considers Medicover AB to be Fairly Valued.
Key valuation signals for LTS:0RPS:
ROC (Joel Greenblatt) %: 16.86% (29% above median its 10-year median of 13.02)
GF Value™: kr234.72 vs. price of kr223.00 (5% below fair value)
Industry Position: 35.3% above the Healthcare Providers & Services median (#293 of 669)
No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
89GF Score
Get the complete analysis for LTS:0RPS
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RPS has been successfully added to your 
